TrialMolecular therapy : the journal of the American Society of Gene Therapy2012

Phase II trial of intravenous administration of Reolysin(®) (Reovirus Serotype-3-dearing Strain) in patients with metastatic melanoma.

Evanthia Galanis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.